A Research Study to See How Well CagriSema Compared to Tirzepatide Helps People With Obesity Lose Weight
Clinical trial NCT06131437 · COMPLETED
Trial details
- NCT number
- NCT06131437
- Sponsor
- Novo Nordisk A/S
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-11-27
- Primary completion
- 2025-12-08
- Enrollment
- 809
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.